Compile Data Set for Download or QSAR
maximum 50k data
Found 82 of ic50 data for polymerid = 594
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345287(2-[[1-[(2-Chlorophenyl)methyl]-5-[3- (cyclopropyl...)
Affinity DataIC50:  54.5nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345295(1-[[1-[(2-Chlorophenyl)methyl]-5-(3- methoxypheny...)
Affinity DataIC50:  100nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345271(1-[[5-(4-Chlorophenyl)-1-[(2- chlorophenyl)methyl...)
Affinity DataIC50:  100nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345298(2-[[1-[(2-Chlorophenyl)methyl]-5-[3- (cyclopentyl...)
Affinity DataIC50:  204nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345291(2-[[1-[(2-Chlorophenyl)methyl]-5-[3- (cyclobutoxy...)
Affinity DataIC50:  204nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345281(2-[[1-[(2-Chlorophenyl)methyl]-5-(3- isobutoxyphe...)
Affinity DataIC50:  302nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345260(2-[[5-(4-Chlorophenyl)-1-[(2,4- dichlorophenyl)me...)
Affinity DataIC50:  303nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345334(US10202350, Example 81 | US10214492, Example 81 | ...)
Affinity DataIC50:  303nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345259(2-[[5-(4-Chlorophenyl)-1-[(2,4- dichlorophenyl)me...)
Affinity DataIC50:  400nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345296(2-[[1-[(2-Chlorophenyl)methyl]-5-[3- (cyclobutylm...)
Affinity DataIC50:  404nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345264(2-[[5-(3-Chlorophenyl)-1-[(2- chlorophenyl)methyl...)
Affinity DataIC50:  404nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345274(2-[[5-(4-Chlorophenyl)-1-[(2- chlorophenyl)methyl...)
Affinity DataIC50:  454nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345305(US10202350, Example 51 | US10214492, Example 51 | ...)
Affinity DataIC50:  6.00E+3nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345331(US10202350, Example 77 | US10214492, Example 77 | ...)
Affinity DataIC50:  9.00E+3nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345293(2-[[1-[(2-Chlorophenyl)methyl]-5-[3- (cyclopropox...)
Affinity DataIC50:  1.00E+4nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345288(2-[[1-[(2-Chlorophenyl)methyl]-5-[3- (trifluorome...)
Affinity DataIC50:  1.10E+4nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345315(2-([1-[(2-methoxyphenyl)methyl]-5-[3-(2- methylpr...)
Affinity DataIC50:  1.10E+4nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345327(2-([1-[(2-chlorophenyl)methyl]-5-[3-[(2-methylprop...)
Affinity DataIC50:  1.10E+4nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345299(2-[[1-[(2-Chlorophenyl)methyl]-5-[3- (tetrahydrop...)
Affinity DataIC50:  1.20E+4nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345319(US10202350, Example 65 | US10214492, Example 65 | ...)
Affinity DataIC50:  1.30E+4nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345282(2-[[1-[(2-Chlorophenyl)methyl]-5-(3- ethoxyphenyl...)
Affinity DataIC50:  1.50E+4nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345332(2-[[1-[(2-Chlorophenyl)methyl]-5-(3-hydroxyphenyl)...)
Affinity DataIC50:  1.50E+4nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345283(2-[[1-[(2-Bromophenyl)methyl]-5-(3- isopropoxyphe...)
Affinity DataIC50:  1.60E+4nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345335(Methyl 2-[[1-[(2-chlorophenyl)methyl]-5-(3-methoxy...)
Affinity DataIC50:  1.60E+4nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345267(2-[[1-[(2-Chlorophenyl)methyl]-5-[3- (trifluorome...)
Affinity DataIC50:  1.70E+4nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345321(2-([1-(o-Chlorophenyl)methyl]-5-(m-methoxyphenyl)-...)
Affinity DataIC50:  1.70E+4nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345317(2-([1-[(4-methoxyphenyl)methyl]-5-[3-(2- methylpr...)
Affinity DataIC50:  1.70E+4nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345257(2-[[5-(4-Chlorophenyl)-1-[(2- chlorophenyl)methyl...)
Affinity DataIC50:  2.50E+4nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345322(2-([1-[(2-Chlorophenyl)methyl]-5-(3-methoxyphenyl)...)
Affinity DataIC50:  2.60E+4nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345284(2-[[1-[(2-Bromophenyl)methyl]-5-(3- methoxyphenyl...)
Affinity DataIC50:  2.70E+4nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345308(2-({1-[(o-Chlorophenyl)methyl]-5-(m- methoxypheny...)
Affinity DataIC50:  2.70E+4nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345316(2-([1-[(3-methoxyphenyl)methyl]-5-[3-(2- methylpr...)
Affinity DataIC50:  2.70E+4nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345280(2-[[1-[(2-Fluorophenyl)methyl]-5-(3- isobutoxyphe...)
Affinity DataIC50:  2.70E+4nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345265(2-[[1-[(2-Chlorophenyl)methyl]-5-(m- tolyl)pyrazo...)
Affinity DataIC50:  2.90E+4nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345256(2-[[5-(4-Chlorophenyl)-1-[(4- chlorophenyl)methyl...)
Affinity DataIC50:  2.90E+4nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345269(2-[[1-[(2-Chlorophenyl)methyl]-5- cyclohexyl-pyra...)
Affinity DataIC50:  3.30E+4nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345297(2-[[1-[(2-Chlorophenyl)methyl]-5-[3- (2,2,2-trifl...)
Affinity DataIC50:  3.30E+4nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345258(2-[[1-[(2-Chlorophenyl)methyl]-5-(4- fluorophenyl...)
Affinity DataIC50:  3.30E+4nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345304(2-([1-[(o-Chlorophenyl)methyl]-5-[m- (dimethylami...)
Affinity DataIC50:  3.40E+4nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345330(US10202350, Example 76 | US10214492, Example 76 | ...)
Affinity DataIC50:  3.80E+4nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345263(2-[[5-(2-Chlorophenyl)-1-[(2- chlorophenyl)methyl...)
Affinity DataIC50:  3.90E+4nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345285(2-[[1-[(2-Isopropylphenyl)methyl]-5-(3- methoxyph...)
Affinity DataIC50:  4.20E+4nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345314(US10202350, Example 60 | US10214492, Example 60 | ...)
Affinity DataIC50:  4.40E+4nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345318(US10202350, Example 64 | US10214492, Example 64 | ...)
Affinity DataIC50:  4.50E+4nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345326(US10202350, Example 72 | US10214492, Example 72 | ...)
Affinity DataIC50:  4.50E+4nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345320(2-([1-[(2-chlorophenyl)methyl]-5-(5-methoxythiophe...)
Affinity DataIC50:  4.50E+4nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345272(2-[[1-[(2-Chlorophenyl)methyl]-5-thiazol- 2-yl-py...)
Affinity DataIC50:  4.50E+4nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345262(2-[[1-[(2-Chlorophenyl)methyl]-5-phenyl- pyrazol-...)
Affinity DataIC50:  4.60E+4nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345300(2-[[1-[(2-Chlorophenyl)methyl]-5-(3- morpholinoph...)
Affinity DataIC50:  4.70E+4nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMalignant T-cell-amplified sequence 1(Homo sapiens (human))
Vettore

US Patent
LigandPNGBDBM345255(US10202350, Example 1 | US11724989, Example 1)
Affinity DataIC50:  5.00E+4nMAssay Description:MCT1 activity may be measured using BT-20 breast cancer cells that express high native levels of MCT1, but do not express MCT4 and are known to those...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 82 total ) | Next | Last >>
Jump to: